X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37) 37
humans (31) 31
female (20) 20
life sciences (16) 16
male (16) 16
pharmacology & pharmacy (16) 16
adult (15) 15
middle aged (12) 12
risk (12) 12
pharmacoepidemiology (11) 11
pharmacovigilance (11) 11
diabetes (10) 10
aged (9) 9
human health and pathology (9) 9
aged, 80 and over (8) 8
cancer (8) 8
diabetes mellitus, type 2 - drug therapy (7) 7
pharmacology (7) 7
abridged index medicus (6) 6
bias (6) 6
clinical trials (6) 6
databases (6) 6
disproportionality analysis (6) 6
france (6) 6
hypoglycemic agents - adverse effects (6) 6
adverse drug reactions (5) 5
association (5) 5
diabetes mellitus (5) 5
drugs (5) 5
health risk assessment (5) 5
medicine, general & internal (5) 5
pharmaceutical sciences (5) 5
pioglitazone (5) 5
prescription drugs (5) 5
retrospective studies (5) 5
safety (5) 5
surgery (5) 5
type 2 diabetes (5) 5
adolescent (4) 4
adverse drug-reactions (4) 4
animals (4) 4
biomedicine (4) 4
cohort studies (4) 4
data bases (4) 4
dipeptidyl-peptidase iv inhibitors - adverse effects (4) 4
metformin (4) 4
pharmacology/toxicology (4) 4
practice research database (4) 4
pregnancy (4) 4
research (4) 4
risk factors (4) 4
thiazolidinediones - adverse effects (4) 4
treatment outcome (4) 4
urinary bladder neoplasms - chemically induced (4) 4
usage (4) 4
young adult (4) 4
[ sdv.sp.pharma ] life sciences [q-bio]/pharmaceutical sciences/pharmacology (3) 3
bladder cancer (3) 3
bladder-cancer (3) 3
competition bias (3) 3
confidence intervals (3) 3
databases, factual (3) 3
dermatology (3) 3
disproportionality (3) 3
endocrinology and metabolism (3) 3
glucagon-like peptide 1 - analogs & derivatives (3) 3
hematology (3) 3
hypoglycemia (3) 3
immortal time bias (3) 3
insulin (3) 3
internal medicine (3) 3
mellitus (3) 3
obstetrics & gynecology (3) 3
pancreas (3) 3
patients (3) 3
peripheral vascular disease (3) 3
psychiatry (3) 3
public, environmental & occupational health (3) 3
reporting odds ratio (3) 3
risk assessment (3) 3
side effects (3) 3
studies (3) 3
suicide (3) 3
[ sdv ] life sciences [q-bio] (2) 2
acute coronary syndromes (2) 2
analysis (2) 2
antibiotics (2) 2
biais (2) 2
biases (2) 2
bladder (2) 2
case-control studies (2) 2
case–non case study (2) 2
classification (2) 2
diabetics (2) 2
disorders (2) 2
diversion (2) 2
drug (2) 2
drug dosages (2) 2
drug safety (2) 2
drug therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapie, ISSN 0040-5957, 05/2018, Volume 73, Issue 3, pp. 247 - 255
Case–non case studies belongs to the methods assessing drug safety by analyzing the disproportionality of notifications of adverse drug reactions in... 
Pharmacoepidemiology | Reporting odds ratio | Disproportionality analysis | Bias | Case–non case study | Pharmacovigilance
Journal Article
Therapie, ISSN 0040-5957, 04/2019, Volume 74, Issue 2, pp. 225 - 232
Journal Article
THERAPIE, ISSN 0040-5957, 05/2018, Volume 73, Issue 3, pp. 247 - 255
Case-non case studies belongs to the methods assessing drug safety by analyzing the disproportionality of notifications of adverse drug reactions in... 
COMPETITION BIAS | BLADDER-CANCER | Reporting odds ratio | Case-non case study | Disproportionality analysis | Bias | Pharmacovigilance | ADVERSE DRUG-REACTIONS | Pharmacoepidemiology | SIGNAL-DETECTION | PIOGLITAZONE | HYPOGLYCEMIA | PHARMACOLOGY & PHARMACY | SPONTANEOUS REPORTING DATABASES | EVENT REPORTS
Journal Article
Therapie, 04/2019, Volume 74, Issue 2, p. 255
In the field of diabetes, pharmacoepidemiologic (PE) studies are numerous and represent an essential tool to assess the real life effects of diabetes drugs.... 
Journal Article
Psychopharmacology, ISSN 0033-3158, 7/2016, Volume 233, Issue 13, pp. 2503 - 2511
Several case-reports suggest that the use of quinolones may increase the risk of psychiatric adverse reactions such as suicidal behaviors.The aim of this study... 
Suicidal behaviors | Neurosciences | Biomedicine | Psychopharmacology | Adverse drug reactions | Pharmacology/Toxicology | Suicide | Psychiatry | Quinolones | Life Sciences | Human health and pathology | Pharmacology | Neurons and Cognition | Pharmaceutical sciences | Psychiatrics and mental health
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 02/2016, Volume 25, Issue 2, pp. 212 - 214
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2015, Volume 80, Issue 4, pp. 779 - 780
Journal Article
Therapie, ISSN 0040-5957, 04/2016, Volume 71, Issue 2, pp. 211 - 216
The aim of this article is to discuss the contribution of pharmacoepidemiology to pharmacovigilance in the context of drug safety monitoring. Because this... 
Drug | Pharmacoepidemiology | Surveillance | Risk | Pharmacovigilance
Journal Article
British Medical Journal, ISSN 0959-8146, 06/2012, Volume 344, Issue 7862, p. 7
In a linked study, Azoulay and colleagues found that more than two years daily exposure to pioglitazone doubted the risk of bladder cancer. They also found an... 
Prescription drugs | Bladder | Diabetes | Drug therapy | Cancer
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e16126 - e16126
Journal Article
Therapie, ISSN 0040-5957, 2018
Aim of the study: Metformin is recommended as the first-line treatment of type 2 diabetes mellitus. Despite its common use, few studies have been conducted to... 
Metformin | Type 2 diabetes mellitus | Meta-analysis | Randomized controlled trials
Journal Article
Therapie, ISSN 0040-5957, 04/2019, Volume 74, Issue 2, pp. 255 - 260
In the field of diabetes, pharmacoepidemiologic (PE) studies are numerous and represent an essential tool to assess the real life effects of diabetes drugs.... 
Pharmacoepidemiology | Database studies | Diabetes mellitus | Post-marketing surveillance | Real-world evidence | MORTALITY | EVENTS | GLUCOSE-LOWERING MEDICATIONS | HEART-FAILURE | RISK | MELLITUS | IMMORTAL TIME BIAS | HYPOGLYCEMIA | PHARMACOLOGY & PHARMACY | ASSOCIATION | INCRETIN-BASED DRUGS | Index Medicus
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2018, Volume 136, Issue 7, p. 770
Importance Amyloid-β is a major component of retinal drusen, the primary lesions of age-related macular degeneration (AMD), and autopsy and animal models... 
Animal models | Antiinflammatory agents | Retina | Inflammation | Epithelium | Retinal pigment epithelium | Macular degeneration | Atrophy | Neurodegeneration | Autopsy | Acetylcholine receptors | Ophthalmology | Drug use | Smoking
Journal Article
Therapie, ISSN 0040-5957, 04/2016, Volume 71, Issue 2, pp. 203 - 209
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 12/2019, Volume 75, Issue 12, pp. 1705 - 1711
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.